Method for generating a three-dimensional nucleic acid containing matrix

US10494662B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10494662-B2
Application numberUS-201715786921-A
CountryUS
Kind codeB2
Filing dateOct 18, 2017
Priority dateMar 12, 2013
Publication dateDec 3, 2019
Grant dateDec 3, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods of making a three-dimensional matrix of nucleic acids within a cell is provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for nucleic acid sequence identification, comprising (a) providing a container comprising a biological sample comprising a first plurality of nucleic acid molecules having a relative three-dimensional spatial relationship that is fixed, wherein said first plurality of nucleic acid molecules is a plurality of ribonucleic acid molecules; (b) in said container, contacting said biological sample comprising said first plurality of nucleic acid molecules having said relative three-dimensional spatial relationship that is fixed with matrix-forming material to generate a three-dimensional polymer matrix that encapsulates said first plurality of nucleic acid molecules of said biological sample, wherein said three-dimensional polymer matrix is formed of a material separate from said first plurality of nucleic acid molecules; (c) using said first plurality of nucleic acid molecules to generate a second plurality of nucleic acid molecules immobilized to said three-dimensional polymer matrix, which second plurality of nucleic acid molecules have said relative three-dimensional spatial relationship; and (d) identifying sequences of said second plurality of nucleic acid molecules while said second plurality of nucleic acid molecules is coupled to said three-dimensional polymer matrix. 2. The method of claim 1 , further comprising generating said three-dimensional polymer matrix by polymerizing or cross-linking said matrix-forming material. 3. The method of claim 2 , further comprising contacting said first plurality of nucleic acid molecules having said relative three-dimensional spatial relationship within said biological sample with said matrix-forming material. 4. The method of claim 3 , further comprising, prior to (a), permeabilizing said biological sample. 5. The method of claim 2 , wherein (b) further comprises using a polymerization inducing catalyst, ultraviolet light, or functional cross-linkers to subject said matrix-forming material to polymerization. 6. The method of claim 1 , further comprising subjecting said first plurality of nucleic acid molecules to nucleic acid amplification to generate said second plurality of nucleic acid molecules within said three-dimensional polymer matrix. 7. The method of claim 6 , wherein said subjecting said first plurality of nucleic acid molecules to said nucleic acid amplification comprises introducing reagents into said three-dimensional polymer matrix. 8. The method of claim 7 , wherein said reagents are introduced into said three-dimensional polymer matrix through pores of said three-dimensional polymer matrix. 9. The method of claim 6 , further comprising subjecting said second plurality of nucleic acid molecules to conditions sufficient to couple said second plurality of nucleic acid molecules to said three-dimensional polymer matrix. 10. The method of claim 9 , wherein said second plurality of nucleic acid molecules couple to said three-dimensional polymer matrix by forming covalent bonds to said three-dimensional polymer matrix. 11. The method of claim 6 , further comprising subjecting said second plurality of nucleic acid molecules to conditions sufficient to cross-link said second plurality of nucleic acid molecules to said three-dimensional polymer matrix. 12. The method of claim 6 , wherein said nucleic acid amplification comprises rolling circle amplification or comprises use of polymerase chain reaction. 13. The method of claim 1 , wherein (d) comprises subjecting said second plurality of nucleic acid molecules or derivatives thereof to sequencing to identify said sequences. 14. The method of claim 13 , wherein said sequencing comprises detecting signals indicative of said sequences. 15. The method of claim 14 , wherein said signals are optical signals. 16. The method of claim 1 , wherein said first plurality of nucleic acid molecules comprises a plurality of transcripts. 17. The method of claim 16 , further comprising, prior to (d), subjecting said plurality of transcripts to reverse transcription to yield complementary deoxyribonucleic acid (cDNA) molecules, wherein said sequences identified in (d) are sequences of said cDNA molecules. 18. The method of claim 1 , wherein said biological sample is a tissue from a subject. 19. The method of claim 1 , wherein said second plurality of nucleic acid molecules comprises a functional moiety that couples said second plurality of nucleic acid molecules to said three-dimensional polymer matrix. 20. The method of claim 19 , wherein said functional moiety covalently couples said second plurality of nucleic acid molecule to said three-dimensional polymer matrix. 21. The method of claim 1 , further comprising contacting said biological sample with a preservation agent. 22. The method of claim 1 , wherein said three-dimensional polymer matrix is optically transparent, and wherein (d) comprises optically imaging said three-dimensional polymer matrix to identify said sequences of said second plurality of nucleic acid molecules. 23. The method of claim 1 , wherein said first plurality of nucleic acid molecules is covalently bound to said three-dimensional polymer matrix. 24. The method of claim 23 , wherein said first plurality of nucleic acid molecules is covalently bound to said three-dimensional polymer matrix via cross-linking. 25. The method of claim 1 , wherein said identifying said sequences of said second plurality of nucleic acid molecule comprises hybridizing probes to said second plurality of nucleic acid molecules or derivatives thereof, wherein said probes comprise detectable labels corresponding to said sequences. 26. The method of claim 1 , wherein said biological sample is a cell.

Assignees

Inventors

Classifications

  • Methods for sequencing · CPC title

  • involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

  • Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • Nucleic acid amplification reactions · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10494662B2 cover?
Methods of making a three-dimensional matrix of nucleic acids within a cell is provided.
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification C12Q1/6806. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).